The Congressional Budget Office (CBO) launched its latest mistaken Obamacare-related estimate this week, predicting that a House-passed bill to repeal and replace the embattled law would lead to 23 million more uninsured people by 2026. Although CBO itself acknowledges that this latest prediction is “especially uncertain,” one thing is especially certain: CBO is wrong. We explain why at … [Read more...] about CBO Is Wrong And Its Numbers Shouldn’t Deter Needed Reform
Archives for May 2017
The CBO Bludgeon
Bureaucratic oracles at the Congressional Budget Office (CBO) have decreed that 23 million fewer people will have health coverage in 2026 if a House-passed bill to repeal and replace Obamacare were to become law. As with CBO’s past Obamacare-related pronouncements, corporate and social media sources are uncritically repeating that estimate, overlooking the questionable assumptions that underlie … [Read more...] about The CBO Bludgeon
More and better information can enhance patient care
With Congress intensely focused on big decisions involving health reform legislation, it’s easy to miss other initiatives that are quietly moving through Congress which could make a major contribution to achieving the goals of health reform One example is a measure offered by Rep. Morgan Griffith (R-VA) that would open the lines of communication between biopharmaceutical, medical device, and … [Read more...] about More and better information can enhance patient care
New Taxes Won’t Lower Drug Prices
Prescription drug prices continue to be a hot political issue, with the Trump administration preparing to release an action plan as soon as repeal and replace legislation clears Congress. Mick Mulvaney, who heads the White House budget office and is participating in the talks, floated an idea last week that should quickly be crossed off the list of policy ideas. He told the LIGHT 2017 Forum at … [Read more...] about New Taxes Won’t Lower Drug Prices